Vaughan David Investments LLC IL Buys 2,521 Shares of Cigna Group $CI

Vaughan David Investments LLC IL increased its stake in Cigna Group (NYSE:CI) by 1.8% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 145,682 shares of the health services provider’s stock after acquiring an additional 2,521 shares during the quarter. Vaughan David Investments LLC IL’s holdings in Cigna Group were worth $40,096,000 at the end of the most recent reporting period.

Several other hedge funds also recently modified their holdings of the stock. CSM Advisors LLC increased its stake in shares of Cigna Group by 8.6% in the 4th quarter. CSM Advisors LLC now owns 77,248 shares of the health services provider’s stock valued at $21,261,000 after acquiring an additional 6,149 shares in the last quarter. Barrow Hanley Mewhinney & Strauss LLC increased its stake in shares of Cigna Group by 6.4% in the 4th quarter. Barrow Hanley Mewhinney & Strauss LLC now owns 14,584 shares of the health services provider’s stock valued at $4,014,000 after acquiring an additional 874 shares in the last quarter. Meeder Asset Management Inc. increased its stake in shares of Cigna Group by 117.5% in the 4th quarter. Meeder Asset Management Inc. now owns 5,634 shares of the health services provider’s stock valued at $1,551,000 after acquiring an additional 3,044 shares in the last quarter. Empowered Funds LLC increased its stake in shares of Cigna Group by 61.0% in the 4th quarter. Empowered Funds LLC now owns 130,858 shares of the health services provider’s stock valued at $36,016,000 after acquiring an additional 49,604 shares in the last quarter. Finally, Inceptionr LLC bought a new stake in shares of Cigna Group in the 4th quarter valued at $860,000. Institutional investors own 86.99% of the company’s stock.

Cigna Group Price Performance

CI opened at $294.64 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.73 and a quick ratio of 0.73. The company has a market capitalization of $77.94 billion, a price-to-earnings ratio of 12.49, a P/E/G ratio of 1.14 and a beta of 0.28. The firm’s fifty day moving average price is $281.93 and its two-hundred day moving average price is $277.87. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CI) last posted its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $7.60 by $0.19. The firm had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a net margin of 2.26% and a return on equity of 19.75%. The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts anticipate that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Shareholders of record on Thursday, June 4th will be issued a dividend of $1.56 per share. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s payout ratio is currently 26.45%.

Analyst Upgrades and Downgrades

CI has been the subject of several research analyst reports. Deutsche Bank Aktiengesellschaft lowered shares of Cigna Group from a “buy” rating to a “hold” rating and lowered their price objective for the company from $303.00 to $302.00 in a research note on Wednesday, May 20th. Raymond James Financial set a $340.00 price target on shares of Cigna Group in a research note on Friday, May 1st. Weiss Ratings restated a “hold (c)” rating on shares of Cigna Group in a research note on Monday, June 1st. UBS Group boosted their price target on shares of Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a research note on Friday, May 22nd. Finally, The Goldman Sachs Group boosted their price target on shares of Cigna Group from $335.00 to $340.00 and gave the company a “buy” rating in a research note on Monday, May 4th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and six have assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $338.80.

Insider Transactions at Cigna Group

In other Cigna Group news, CEO David Cordani sold 201,878 shares of Cigna Group stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the transaction, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. The trade was a 85.46% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.